Pulmatrix, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Pulmatrix, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales grew in 2 of the last 3 years; profit grew in 3 of 3. Steadier than 85% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
2/3 · 3/3Sales grew in 2 of the last 3 years; profit grew in 3 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 100%
Sales fell 100% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-100% / -90%In 3 years sales changed by -100% while total assets changed by -90%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (9)
Pulmatrix, Inc. made a loss over the last year. Pulmatrix, Inc. owes $0.21 for every $1 it owns. Pulmatrix, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossPulmatrix, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
2.11The share price is 2.11 times Pulmatrix, Inc.'s book value per share, lower than 56% of Healthcare companies in United States.
Market cap
$5 MThe total market value of all of Pulmatrix, Inc.'s shares at today's price (share price × number of shares), smaller than 92% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
$3 MWhat Pulmatrix, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.70Net worth divided by the number of shares. The share price of $1.48 is 2.1 times this, which is the P/B above.
Return on equity (ROE)
-98.3%Pulmatrix, Inc. lost 98.3% of its shareholders' money over the last year, lower than 70% of Healthcare companies in United States.
Owes vs Owns
0.21×Pulmatrix, Inc. owes $0.21 for every $1 it owns (low), lower than 71% of Healthcare companies in United States.
Dividend yield
NonePulmatrix, Inc. does not currently pay a dividend.
Profit growth
LossPulmatrix, Inc. made a loss in each of the last two years.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Pulmatrix, Inc.: $5 M ÷ $3 M (30 Jun 2026) = 2.1.
What is Pulmatrix, Inc.'s return on equity?
Pulmatrix, Inc. lost 98.3% of its shareholders' money over the last year, lower than 70% of Healthcare companies in United States.
How much does Pulmatrix, Inc. owe compared with what it owns?
Pulmatrix, Inc. owes $0.21 for every $1 it owns (low), lower than 71% of Healthcare companies in United States.
Does Pulmatrix, Inc. pay a dividend?
No. Pulmatrix, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.